作者：Francesco Massari^a ; ^{fmassari79@gmail.com" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Alessandra Modena^a ; ^{alessandra.modena@alice.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Chiara Ciccarese^a ; ^{ciccarese.c@gmail.com" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Sara Pilotto^a ; ^{sara.pilotto.85@alice.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Francesca Maines^g ; ^{francesca.maines@gmail.com" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Sergio Bracarda^b ; ^{sergio.bracarda@usl8.toscana.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Isabella Sperduti^c ; ^{isperduti@yahoo.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Diana Giannarelli^c ; ^{giannarelli@ifo.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Paolo Carlini^d ; ^{paolo_carlini@yahoo.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Daniele Santini^e ; ^{d.santini@unicampus.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Giampaolo Tortora^a ; ^{giampaolo.tortora@univr.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Camillo Porta^f ; ¹ ; ² ; ^{c.porta@smatteo.pv.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Emilio Bria^a ; ¹ ; ² ; ^{emilio.bria@univr.it" class="auth_mail" title="E-mail the corresponding author}Author Vitae

关键词：Prostate cancer ; Chemotherapy ; Hormonal therapy ; Immunotherapy ; Overall survival

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

作者：Prof Brian I Rini ; MD^a ; ^{rinib2@ccf.org" class="auth_mail" title="E-mail the corresponding author} ; Prof Arnulf Stenzl ; MD^b ; Prof Romauld Zdrojowy ; MD^c ; Prof Mikhail Kogan ; MD^d ; Mikhail Shkolnik ; MD^e ; Prof Stephane Oudard ; MD^f ; Prof Steffen Weikert ; MD^g ; Prof Sergio Bracarda ; MD^h ; Simon J Crabb ; PhDⁱ ; Prof Jens Bedke ; MD^b ; Joerg Ludwig ; PhD^j ; Dominik Maurer ; PhD^j ; Regina Mendrzyk ; PhD^j ; Claudia Wagner ; PhD^j ; Andrea Mahr ; PhD^j ; Jens Fritsche ; PhD^j ; Toni Weinschenk ; PhD^j ; Steffen Walter ; PhD^j ; Alexandra Kirner ; PhD^j ; Harpreet Singh-Jasuja ; PhD^j ; Carsten Reinhardt ; MD^j ; Tim Eisen ; FRCP^k

刊名：The Lancet Oncology

出版年：2016

作者：Sergio Bracarda ; Michele Sisani ; Francesca Marrocolo ; Alketa Hamzaj ; Sabrina del Buono ; Valeria De Simone

关键词：Renal cell carcinoma ; Sorafenib ; Pazopanib ; Everolimus ; Sunitinib ; Bevacizumab ; Axitinib ; Antiangiogenic therapy ; Treatment algorithm

刊名：Critical Reviews in Oncology/Hematology

出版年：March, 2014

作者：Giuseppe Di Lorenzo ; Sergio Bracarda ; Carlo Buonerba ; Michele Aieta ; Vincenzo Mirone

刊名：European Urology

出版年：February, 2014

作者：Sergio Bracarda^a ; ^b ; ^{sergio.bracarda@usl8.toscana.it} ; Camillo Porta^c ; Corrado Boni^d ; Armando Santoro^e ; Claudia Mucciarini^f ; Antonio Pazzola^g ; Enrico Cortesi^h ; Donatello Gasparroⁱ ; Roberto Labianca^j ; Francesco Di Costanzo^k ; Alfredo Falcone^l ; Michela Cinquini^m ; Claudia Casertaⁿ ; Chiara Paglino^c ; Verena De Angelis^b

关键词：Antiangiogenic therapy ; Interferon-¦Á2a ; Renal cell carcinoma ; Sorafenib

刊名：European Urology

出版年：2013

作者：Sergio Bracarda ; ^{sergio.bracarda@usl8.toscana.it} ; ^{sergiobracarda@gmail.com}

刊名：European Urology

出版年：2013

作者：Erik B. Cornel ; ^{erikcornel@home.nl}

刊名：European Urology

出版年：2012

作者：Vincenzo Pagliarulo^a ; ^{vpagliarulo@urologia.uniba.it} ; ^{enzopagliarulo@yahoo.com} ; Nicolas Mottet^b ; Fritz H. Schrö ; der^c

刊名：European Urology

出版年：2012

作者：Sergio Bracarda^a ; ^b ; ^{sergio.bracarda@usl8.toscana.it}Author Vitae ; Michele Sisani^aAuthor Vitae ; Sabrina Del Buono^aAuthor Vitae ; Ori Ishiwa^aAuthor Vitae ; Francesco Montagnani^aAuthor Vitae ; on behalf of AROME ¹

关键词：Prostate cancer ; Urothelial cancer ; Renal cell carcinoma ; Predictive factors ; Prognostic factors

刊名：Critical Reviews in Oncology/Hematology

出版年：2012

作者：Bernard Escudier^a ; ^{Bernard.Escudier@igr.fr} ; Susanne Osanto^b ; ¹ ; ^{s.osanto@lumc.nl} ; Bö ; rje Ljungberg^c ; ² ; ^{borje.ljungberg@urologi.umu.se} ; Camillo Porta^d ; ³ ; ^{c.porta@smatteo.pv.it} ; John Wagstaff^e ; ⁴ ; ^{john.wagstaff@swansea.ac.uk} ; Peter Mulders^f ; ⁵ ; ^{p.mulders@uro.umcn.nl} ; Martin Gore^g ; ⁶ ; ^{martin.gore@rmh.nhs.uk} ; Axel Bex^h ; ⁷ ; ^a.bex@nki.nl ; Joaquim Bellmuntⁱ ; ⁸ ; ^{jbellmunt@parcdesalutmar.cat} ; Sergio Bracarda^j ; ⁹ ; ^{sergio.bracarda@usl8.toscana.it} ; Alex Franklin^e ; Per Hartvig Honoré ; ^k ; ¹⁰ ; ^{peh@farma.ku.dk} ; Alain Ravaud^l ; ¹¹ ; ^{alain.ravaud@chu-bordeaux.fr} ; Jeanne van Steijn^b ; Zeba Aziz^m ; ¹² ; ^{azizzeba@gmail.com} ; Hideyuki Akazaⁿ ; ¹³ ; ^{akazah@md.tsukuba.ac.jp}

关键词：Renal cell carcinoma ; Targeted agents ; Multidisciplinary management

刊名：Cancer Treatment Reviews

出版年：2012